Delitala G, Giusti M, Rodriguez G, Mazzocchi G, Ferrini S, Baccelliere L, Montano V, Rosadini G, Giordano G
Acta Endocrinol (Copenh). 1982 Jul;100(3):321-6. doi: 10.1530/acta.0.1000321.
To evaluate the role of endogenous opioid peptides in prolactin (Prl), growth hormone (GH) and cortisol neuroregulation, 50 mg of the opiate antagonist naloxone was infused over 24 h to 6 normal male volunteers. An additional naloxone dose (5 mg) was given iv as a bolus injection at 20.00 h. blood specimens were collected hourly by means of a portable constant withdrawal pump. Naloxone failed to alter 24 h secretion of GH and Prl. The sleep-related GH and Prl rise was also unaffected by the opiate blocker. Moreover, naloxone failed to alter the circadian rhythm of cortisol and its 24 h concentration. The results do not suggest, a major role of opiate receptors in spontaneous GH, Prl and cortisol secretion in man.
为评估内源性阿片肽在催乳素(Prl)、生长激素(GH)和皮质醇神经调节中的作用,对6名正常男性志愿者在24小时内输注50毫克阿片拮抗剂纳洛酮。在20:00时静脉推注额外剂量的纳洛酮(5毫克)。通过便携式恒速抽血泵每小时采集血样。纳洛酮未能改变GH和Prl的24小时分泌。与睡眠相关的GH和Prl升高也不受阿片阻滞剂的影响。此外,纳洛酮未能改变皮质醇的昼夜节律及其24小时浓度。结果并不表明阿片受体在人类自发性GH、Prl和皮质醇分泌中起主要作用。